Researchers find clue to stopping breast-cancer metastasis

November 17, 2008,

If scientists knew exactly what a breast cancer cell needs to spread, then they could stop the most deadly part of the disease: metastasis. New research from the University of North Carolina at Chapel Hill School of Medicine takes a step in that direction.

Carol Otey, Ph.D. and UNC colleagues reduced the ability of breast cancer cells to migrate by knocking down the expression of a protein called palladin.

They also found higher levels of palladin in four invasive breast cancer cell lines compared to four non-invasive cell lines.

"This study shows that palladin may play an important role in the metastasis of breast cancer cells as they move out of the tumor and into the blood vessels and lymphatics to spread throughout the body," said Otey, associate professor of cell and molecular physiology.

To conduct the study, the researchers grew breast cancer cells in an "invasion chamber," in which human tumor cells are placed in a plastic well that is inserted into a larger well. Cells will attempt to move to the bottom of the chamber because it's baited with growth factors that cells find attractive. But first the cells have to migrate through a filter coated with a layer of artificial connective tissue. "The cells have to migrate through that and have to degrade it," Otey said. "It's a useful model system that mimics what happens in the body."

The study results appeared in the Nov. 3, 2008, online edition of the journal Oncogene.

Most women would never die from breast cancer if the cancer cells couldn't metastasize to the brain and bone marrow, Otey said. "To really make breast cancer a treatable disease, we have to be able to find a way to prevent or reduce the amount of metastasis."

"Now that we see palladin is expressed mostly in invasive cells, it raises the question as to whether it might be useful as a prognostic marker," Otey said. "Maybe someday doctors could test for the presence of palladin to identify patients who have the most aggressive tumors, then give those patients personalized, more aggressive treatment."

The study benefited from the collaboration between Otey's cell and molecular physiology lab and Dr. Hong Jin ("H.J.") Kim's surgical oncology lab. "I learned a lot from H.J. about the challenges that clinicians face as they try to optimize the treatment of each breast cancer patient," Otey said.

Otey has been investigating palladin's role in cell movement since she discovered and named it in 2000.

Next she will examine a variety of samples of human tumors from a UNC tumor bank, to find out if the tumors from patients who had worse outcomes and more aggressive cancers contain higher levels of palladin.

Source: University of North Carolina School of Medicine

Explore further: Estrogen-mimicking compounds in foods may reduce effectiveness of breast cancer treatment

Related Stories

Estrogen-mimicking compounds in foods may reduce effectiveness of breast cancer treatment

January 11, 2018
Scientists from The Scripps Research Institute (TSRI) have discovered that two estrogen-mimicking compounds found in many foods appear to potently reverse the effects of palbociclib/letrozole, a popular drug combination for ...

Targeting breast cancer through precision medicine

January 9, 2018
University of Alberta researchers have discovered a mechanism that may make cancer cells more susceptible to treatment. The research team found that the protein RYBP prevents DNA repair in cancer cells, including breast cancer.

Scientists identify breast cancer patients who may develop incurable secondary cancers

January 9, 2018
Scientists from King's College London, funded by Breast Cancer Now, believe they have found a way to identify lymph-node positive breast cancer patients who are most likely to develop incurable secondary tumours (metastases) ...

Researchers find protein that mediates formation of HER2-driven breast cancer

January 9, 2018
Researchers at the University of Cincinnati College of Medicine have identified for the first time that the estrogen receptor-binding protein MED1 is a critical mediator of HER2-driven breast cancer, identifying it as a potential ...

Scientists curb growth of cancer cells by blocking access to key nutrients

January 10, 2018
Salk researchers have discovered how to curb the growth of cancer cells by blocking the cells' access to certain nutrients. The approach, detailed in a new paper published today in Nature, took advantage of knowledge on how ...

FDA approves first drug for tumors tied to breast cancer genes

January 12, 2018
(HealthDay)—The U.S. Food and Drug Administration on Friday approved the first drug aimed at treating metastatic breast cancers linked to the BRCA gene mutation.

Recommended for you

T-cells engineered to outsmart tumors induce clinical responses in relapsed Hodgkin lymphoma

January 16, 2018
WASHINGTON-(Jan. 16, 2018)-Tumors have come up with ingenious strategies that enable them to evade detection and destruction by the immune system. So, a research team that includes Children's National Health System clinician-researchers ...

Researchers identify new treatment target for melanoma

January 16, 2018
Researchers in the Perelman School of Medicine at the University of Pennsylvania have identified a new therapeutic target for the treatment of melanoma. For decades, research has associated female sex and a history of previous ...

More evidence of link between severe gum disease and cancer risk

January 16, 2018
Data collected during a long-term health study provides additional evidence for a link between increased risk of cancer in individuals with advanced gum disease, according to a new collaborative study led by epidemiologists ...

Researchers develop a remote-controlled cancer immunotherapy system

January 15, 2018
A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells.

Dietary fat, changes in fat metabolism may promote prostate cancer metastasis

January 15, 2018
Prostate tumors tend to be what scientists call "indolent" - so slow-growing and self-contained that many affected men die with prostate cancer, not of it. But for the percentage of men whose prostate tumors metastasize, ...

Pancreatic tumors may require a one-two-three punch

January 15, 2018
One of the many difficult things about pancreatic cancer is that tumors are resistant to most treatments because of their unique density and cell composition. However, in a new Wilmot Cancer Institute study, scientists discovered ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

E_L_Earnhardt
not rated yet Nov 17, 2008
Metastasis is by "energy" transfered by overactive electrons. "Heat" is a measure of their "spin" and vibration. "Cooling" decreases activity within and without actively dividing cells! No metastasis with cyroablation!



mi cells

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.